Drug Discovery and Development Analysis & Statistics, July 2014 (p40)

Talk to Amrita

+1 718 303 2019

All regions

You might be interested in: clinical trial, drug discovery, drug development, more »

1171-1210 of about 4 400 reports

Purchase Reports From Reputable Market Research Publishers

TRAIL Receptor Agonists -Pipeline Insights, 2014

TRAIL Receptor Agonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“TRAIL Receptor Agonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report ...

  • Industries : Drug Discovery and Development
Transcription Factor Activator Protein-1 (AP-1) Inhibitors -Pipeline Insights, 2014

Transcription Factor Activator Protein-1 (AP-1) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Transcription Factor Activator Protein-1 (AP-1) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action ...

  • Industries : Drug Discovery and Development
Transforming Growth Factor Alpha (TGFa) Inhibitors -Pipeline Insights, 2014

Transforming Growth Factor Alpha (TGFa) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Transforming Growth Factor Alpha (TGFa) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). ...

  • Industries : Drug Discovery and Development
Transforming Growth Factor Beta (TGFb) Inhibitors -Pipeline Insights, 2014

Transforming Growth Factor Beta (TGFb) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Transforming Growth Factor Beta (TGFb) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). ...

  • Industries : Drug Discovery and Development
Transglutaminase 2 Inhibitors -Pipeline Insights, 2014

Transglutaminase 2 Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Transglutaminase 2 Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of ...

  • Industries : Drug Discovery and Development
Transient Receptor Potential Cation Channel, Subfamily A, Member 1 (TRPA1) Antagonists -Pipeline Insights, 2014

Transient Receptor Potential Cation Channel, Subfamily A, Member 1 (TRPA1) Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Transient Receptor Potential Cation Channel, Subfamily A, Member 1 (TRPA1) Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs ...

  • Industries : Drug Discovery and Development
Transient Receptor Potential Cation Channel, Subfamily M, Member 8 (TRPM8) Antagonists -Pipeline Insights, 2014

Transient Receptor Potential Cation Channel, Subfamily M, Member 8 (TRPM8) Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Transient Receptor Potential Cation Channel, Subfamily M, Member 8 (TRPM8) Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs ...

  • Industries : Drug Discovery and Development
TRK1-Transforming Tyrosine Kinase (Trk-A or High Affinity Nerve Growth Factor Receptor) Antagonists -Pipeline Insights, 2014

TRK1-Transforming Tyrosine Kinase (Trk-A or High Affinity Nerve Growth Factor Receptor) Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“TRK1-Transforming Tyrosine Kinase (Trk-A or High Affinity Nerve Growth Factor Receptor) Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline ...

  • Industries : Drug Discovery and Development
Trypsin Inhibitors -Pipeline Insights, 2014

Trypsin Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Trypsin Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report ...

  • Industries : Drug Discovery and Development
Tryptophan Hydroxylase (TPH or Tryptophan 5-Monooxygenase) Inhibitors -Pipeline Insights, 2014

Tryptophan Hydroxylase (TPH or Tryptophan 5-Monooxygenase) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Tryptophan Hydroxylase (TPH or Tryptophan 5-Monooxygenase) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism ...

  • Industries : Drug Discovery and Development
Type 1 Lysophosphatidic Acid Receptor (LPA1) Inhibitors -Pipeline Insights, 2014

Type 1 Lysophosphatidic Acid Receptor (LPA1) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Type 1 Lysophosphatidic Acid Receptor (LPA1) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action ...

  • Industries : Drug Discovery and Development
Ubiquitin Specific Proteases (USP) Inhibitors -Pipeline Insights, 2014

Ubiquitin Specific Proteases (USP) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Ubiquitin Specific Proteases (USP) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A ...

  • Industries : Drug Discovery and Development
UMP-CMP Kinase (UMP-CMPK) Inhibitors -Pipeline Insights, 2014

UMP-CMP Kinase (UMP-CMPK) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“UMP-CMP Kinase (UMP-CMPK) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Drug Discovery and Development
Vascular Endothelial Growth Factor A (VEGF-A) Activator -Pipeline Insights, 2014

Vascular Endothelial Growth Factor A (VEGF-A) Activator -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Vascular Endothelial Growth Factor A (VEGF-A) Activator-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action ...

  • Industries : Drug Discovery and Development
Vascular Endothelial Growth Factor B (VEGF-B) Inhibitors -Pipeline Insights, 2014

Vascular Endothelial Growth Factor B (VEGF-B) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Vascular Endothelial Growth Factor B (VEGF-B) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action ...

  • Industries : Drug Discovery and Development
Vascular Endothelial Growth Factor C (VEGF-C) Inhibitors -Pipeline Insights, 2014

Vascular Endothelial Growth Factor C (VEGF-C) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Vascular Endothelial Growth Factor C (VEGF-C) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action ...

  • Industries : Drug Discovery and Development
Vascular Endothelial Growth Factor D (VEGF-D) Inhibitors -Pipeline Insights, 2014

Vascular Endothelial Growth Factor D (VEGF-D) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Vascular Endothelial Growth Factor D (VEGF-D) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action ...

  • Industries : Drug Discovery and Development
Vasoactive Intestinal Polypeptide Receptor 2 (VPAC2 ) Agonists -Pipeline Insights, 2014

Vasoactive Intestinal Polypeptide Receptor 2 (VPAC2 ) Agonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Vasoactive Intestinal Polypeptide Receptor 2 (VPAC2 ) Agonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of ...

  • Industries : Drug Discovery and Development
Vasopressin Receptor Agonists -Pipeline Insights, 2014

Vasopressin Receptor Agonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Vasopressin Receptor Agonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of ...

  • Industries : Drug Discovery and Development
Vasopressin Receptor Antagonists -Pipeline Insights, 2014

Vasopressin Receptor Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Vasopressin Receptor Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Drug Discovery and Development
Vasopressin V1a Receptor (V1aR) Antagonists -Pipeline Insights, 2014

Vasopressin V1a Receptor (V1aR) Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Vasopressin V1a Receptor (V1aR) Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key ...

  • Industries : Drug Discovery and Development
Vasopressin V2 Receptor (V2R) Agonists -Pipeline Insights, 2014

Vasopressin V2 Receptor (V2R) Agonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Vasopressin V2 Receptor (V2R) Agonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Drug Discovery and Development
Vasopressin V2 Receptor (V2R) Antagonists -Pipeline Insights, 2014

Vasopressin V2 Receptor (V2R) Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Vasopressin V2 Receptor (V2R) Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key ...

  • Industries : Drug Discovery and Development
Viral Protease Inhibitors -Pipeline Insights, 2014

Viral Protease Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Viral Protease Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the ...

  • Industries : Drug Discovery and Development
Xanthine Oxidase Inhibitors -Pipeline Insights, 2014

Xanthine Oxidase Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Xanthine Oxidase Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the ...

  • Industries : Drug Discovery and Development
Hypoxia Inducible Factor 1 (HIF-1) Inhibitors -Pipeline Insights, 2014

Hypoxia Inducible Factor 1 (HIF-1) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Hypoxia Inducible Factor 1 (HIF-1) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A ...

  • Industries : Drug Discovery and Development
Janus Kinase 1 (JAK1) Inhibitors -Pipeline Insights, 2014

Janus Kinase 1 (JAK1) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Janus Kinase 1 (JAK1) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Drug Discovery and Development
Janus Kinase 3 (JAK3) Inhibitors -Pipeline Insights, 2014

Janus Kinase 3 (JAK3) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Janus Kinase 3 (JAK3) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Drug Discovery and Development
Matrix Metalloproteinase 13 (MMP-13) Inhibitors -Pipeline Insights, 2014

Matrix Metalloproteinase 13 (MMP-13) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Matrix Metalloproteinase 13 (MMP-13) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). ...

  • Industries : Drug Discovery and Development
Matrix Metalloproteinase 14 (MMP-14) Inhibitors -Pipeline Insights, 2014

Matrix Metalloproteinase 14 (MMP-14) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Matrix Metalloproteinase 14 (MMP-14) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). ...

  • Industries : Drug Discovery and Development

About 200 Companies

Read our Company Profiles

GlaxoSmithKline PLC

United Kingdom

GlaxoSmithKline P.L.C.

United States

Pfizer Inc.

United States

Novartis Inc.

Switzerland

Johnson and Johnson

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.